Neoadjuvant versus adjuvant chemotherapy in urothelial carcinoma of the upper urinary tract. Phase II Randomized Clinical Trial of Feasibility (URANUS)
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: EUROPEAN URO-ONCOLOGY GROUP (EUOG)
- Phase: II
- Execution start: 07/04/2022
- End of execution: 30/12/2025
- IP: MIGUEL ARRABAL MARTIN